1. Stewart JA, Ackerly CC, Myers CF, Newman RA, Krakoff IH: Clinical and clinical-pharmacologic studies of 2-amino-1,3,4-thiadiazole (A-TDA:NSC 4728). Cancer Chemother Pharmacol 16:287–291, 1986
2. Locker GY, Khandekar JD, Krauss S, Relsel H, Hoeltgen T, Wolter J, Haid M, Hoffman R, Blough R, Johnson C: Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial. Cancer Treat Rep 71:649–650, 1987
3. Shevrin DH, McGuire WP, Lanzotti V, Krauss S, Blough R, Cobleigh M, Johnson C, Lad T, Kukla L: Phase II trial of aminothiadiazole in advanced non-small cell lung cancer. Cancer Treat Rep 70:417–418, 1986
4. Locker G, Strond W, Khandekar J, Kram J, Khandekar A, Johnson C: Phase I trial of aminothiadiazole (ATDA) in patients with malignancy: an Illinois Cancer Council (ICC) study. Recent Advances in Chemotherapy: Proceedings 16th International Congress of Chemotherapy 16:746.1–746.2, 1989
5. Locker G, Khandekar J, Kram J, Johnson C: Aminothiadiazole (ATDA) in the treatment of advanced colorectal carcinoma: Illinois Cancer Council experience. Proceedings, American Society Clinical Oncology 8:113, 1989